Cargando…

Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice

Filamentous tau aggregates are hallmark lesions in numerous neurodegenerative diseases, including Alzheimer’s disease (AD). Cell culture and animal studies showed that tau fibrils can undergo cell-to-cell transmission and seed aggregation of soluble tau, but this phenomenon was only robustly demonst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jing L., Narasimhan, Sneha, Changolkar, Lakshmi, He, Zhuohao, Stieber, Anna, Zhang, Bin, Gathagan, Ronald J., Iba, Michiyo, McBride, Jennifer D., Trojanowski, John Q., Lee, Virginia M.Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110027/ https://www.ncbi.nlm.nih.gov/pubmed/27810929 http://dx.doi.org/10.1084/jem.20160833

Ejemplares similares

Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019)

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
por: Gibbons, Garrett S., et al.
Publicado: (2019)

LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons
por: Henderson, Michael X., et al.
Publicado: (2021)

Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
por: Marshall, Courtney A., et al.
Publicado: (2022)

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
por: Gibbons, Garrett S., et al.
Publicado: (2020)

Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor
por: Cornblath, Eli J., et al.
Publicado: (2021)

In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics
por: Xu, Hong, et al.
Publicado: (2021)

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
por: Zhang, Shengnan, et al.
Publicado: (2022)

Tau Antibody Structure Reveals a Molecular Switch Defining a Pathological Conformation of the Tau Protein
por: Chukwu, Jessica E., et al.
Publicado: (2018)

Biomarkers for tau pathology
por: Schöll, Michael, et al.
Publicado: (2019)

Tau Protein: Function and Pathology
por: Rosenmann, Hanna, et al.
Publicado: (2012)

Insulin dysfunction and Tau pathology
por: El Khoury, Noura B., et al.
Publicado: (2014)

Tau Pathology in Parkinson's Disease
por: Zhang, Xue, et al.
Publicado: (2018)

Imaging tau pathology in Parkinsonisms
por: Coakeley, Sarah, et al.
Publicado: (2017)

Neuronal activity enhances tau propagation and tau pathology in vivo
por: Wu, Jessica W., et al.
Publicado: (2016)

Extracellular Tau and Its Potential Role in the Propagation of Tau Pathology
por: Yamada, Kaoru
Publicado: (2017)

The organization of microtubules and Tau in oligodendrocytes: Tau pathology in damaged oligodendrocytes
por: Torii, Tomohiro, et al.
Publicado: (2022)

Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates
por: Zupancic, Jennifer M., et al.
Publicado: (2023)

Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats
por: Stefanova, Natalia A., et al.
Publicado: (2014)

Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
por: Henderson, Michael X., et al.
Publicado: (2019)

Transmission of tauopathy strains is independent of their isoform composition
por: He, Zhuohao, et al.
Publicado: (2020)

Nontransgenic models of breast cancer
por: H Heppner, Gloria, et al.
Publicado: (2000)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
por: Mattsson‐Carlgren, Niklas, et al.
Publicado: (2021)

Elevated CSF GAP-43 is Alzheimer’s disease specific and associated with tau and amyloid pathology
por: Sandelius, Åsa, et al.
Publicado: (2018)

Distribution patterns of tau pathology in progressive supranuclear palsy
por: Kovacs, Gabor G., et al.
Publicado: (2020)

Different tau species lead to heterogeneous tau pathology propagation and misfolding
por: Dujardin, Simon, et al.
Publicado: (2018)

Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
por: Zhao, Shuai, et al.
Publicado: (2022)

Parenchymal border macrophages regulate tau pathology and tau-mediated neurodegeneration
por: Drieu, Antoine, et al.
Publicado: (2023)

Neuronal Models for Studying Tau Pathology
por: Koechling, Thorsten, et al.
Publicado: (2010)

Ubiquilin 2 Is Not Associated with Tau Pathology
por: Nölle, Anna, et al.
Publicado: (2013)

Intersection of pathological tau and microglia at the synapse
por: Vogels, Thomas, et al.
Publicado: (2019)

Editorial: Tau Pathology in Neurological Disorders
por: Do Carmo, Sonia, et al.
Publicado: (2021)

Spectrum of Tau Pathologies in Huntington’s disease
por: Baskota, Swikrity Upadhyay, et al.
Publicado: (2019)

Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice
por: Vitale, Francesca, et al.
Publicado: (2018)

Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology
por: Duquette, Antoine, et al.
Publicado: (2021)

High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration
por: Wheeler, Jeanna M., et al.
Publicado: (2015)

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau
por: Lasagna-Reeves, Cristian A., et al.
Publicado: (2012)

Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
por: Ozcelik, Sefika, et al.
Publicado: (2013)

Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody
por: Luo, Wenjie, et al.
Publicado: (2015)

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology
por: DeFelipe, Javier
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lrp1btsll8poivcag1re2r1pkc